X
19
PL Developments, based in U.S.A, is a pharmaceutical company.
One of their notable products is IBUPROFEN, with a corresponding application number 74916.
Regulatory Information OTC
With a dosage strength 100MG/5ML
Dosage Form Route SUSPENSION; ORAL
Reference Listed Drug No
Approved since 1999-04-30